Sun Pharmaceutical Recalls Sumatriptan Succinate Tablets Due to Impurities
Sun Pharmaceutical Industries is recalling specific lots of Sumatriptan Succinate 50 mg tablets because they failed impurity specifications.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, which typically indicates a temporary or medically reversible adverse health consequence. The source text does not report any specific illnesses, injuries, or fatalities, and the hazard is related to impurity specifications rather than a high-risk pathogen or structural defect.
Plain-English summary
Sun Pharmaceutical Industries, Inc. is recalling specific lots of Sumatriptan Succinate 50 mg tablets. The recall was initiated because the product failed impurities and degradation specifications, resulting in out-of-specification results for a related substance.
The affected products are packaged in 9 (1x9) unit-of-use blister cards (NDC 62756-521-69) and 100-count bottles (NDC 62756-521-88). The specific lot codes involved are JKU1939A, JKU1940A, and JKU1940B with an expiration date of 04/2022, and JKT4175A with an expiration date of 11/2020. The product was distributed throughout the United States to 96 distributors and 1 repacker/relabeler.
Consumers and healthcare providers should check their inventory for these specific lot numbers and expiration dates. If the product matches the recalled description, it should be returned to the pharmacy or supplier for a refund or replacement. Patients should consult their healthcare provider for alternative treatment options if they have been using the affected medication.
The recalled product
- Product
- SUMATRIPTAN SUCCINATE (SUMATRIPTAN SUCCINATE)
- Brand
- SUMATRIPTAN SUCCINATE
- Manufacturer
- Sun Pharmaceutical Industries, Inc.
- Category
- Drug — Prescription Medication
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (5)
- a) JKU1939A
- JKU1940A
- JKU1940B
- exp. date 04/2022 and b) JKT4175A
- exp. date 11/2020
UPCs (2)
- 0362756521889
- 0362756522886
Distribution
Distribution scope not specified by the agency.
Part of a larger recall action
This product is one of 2 recalled by Sun Pharmaceutical Industries, Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 2 products in this recall →Related recalls
Same brand · SUMATRIPTAN SUCCINATE
- HighSumatriptan Succinate tablets recalled due to manufacturing temperature deviations
FDA (Drugs) · 2022-06-15
Same manufacturer · Sun Pharmaceutical Industries, Inc.
See all →- HighSun Pharmaceutical Recalls Carbamazepine Tablets Due to Manufacturing Deviations
FDA (Drugs) · 2026-08-26
- LowFexofenadine Hydrochloride Tablets 180 mg Recalled for Impurities
FDA (Drugs) · 2026-07-08
- HighPerampanel Prescription Tablets Recalled for Labeling Mix-up
FDA (Drugs) · 2026-07-01
- HighBudesonide inhalation ampules contain black and brown specks and particles
FDA (Drugs) · 2026-06-17
- SevereDoxorubicin liposome injection vials contain glass particulate matter
FDA (Drugs) · 2026-06-17
Same hazard · impurities
See all →- LowDabigatran Etexilate Capsules Recalled Due to Impurity Specification Failure
FDA (Drugs) · 2026-08-05
- ModerateGlycopyrrolate Oral Solution Recalled Due to Failed Impurities and Degradation Specifications
FDA (Drugs) · 2026-07-29
- ModerateMethohexital Sodium for Injection Recalled for Failed Impurities and Degradation Specifications
FDA (Drugs) · 2026-07-15
- ModerateMethohexital Sodium 100 mg/10 mL Compounded Drug Recalled Nationwide
FDA (Drugs) · 2026-07-15
- ModerateAlyacen 7/7/7 birth control tablets failed total impurities specification
FDA (Drugs) · 2026-06-24